SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-065655
Filing Date
2017-11-02
Accepted
2017-11-02 16:18:56
Documents
58
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20576_110q.htm 10-Q 1008856
2 EX-31.1 a17-20576_1ex31d1.htm EX-31.1 10785
3 EX-31.2 a17-20576_1ex31d2.htm EX-31.2 11237
4 EX-32.1 a17-20576_1ex32d1.htm EX-32.1 10731
  Complete submission text file 0001104659-17-065655.txt   4045804

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT crvs-20170930.xml EX-101.INS 804927
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crvs-20170930.xsd EX-101.SCH 34173
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crvs-20170930_cal.xml EX-101.CAL 46035
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crvs-20170930_def.xml EX-101.DEF 94049
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT crvs-20170930_lab.xml EX-101.LAB 315915
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crvs-20170930_pre.xml EX-101.PRE 218586
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37719 | Film No.: 171172618
SIC: 2834 Pharmaceutical Preparations